Our Sectors
Helping clients innovate, define their market and regulatory strategy, partner and navigate choppy waters in Life Sciences.
Neuroscience and Neurotech
Guiding clients to navigate regulatory complexities, find and assess key partners and develop ethical innovation and patient-centric business models.
Dental
Advising firms in the dental ecosystem on the adoption of innovative technologies, adherence to new regulations, design and implementation of new business models and ethical practices. Help devise a partnership strategy with other players and assess key competitors.
Longevity and Public Health
The world population is aging fast and longevity research is becoming a strategic public health investment, in search of solutions for healthy aging and for slowing down the aging process.
Managing new and old health crises, which can reverse advances made in longevity, is becoming a new challenge at both macro (public health) level and micro (longevity researchers and businesses) level. We help clients better understand and navigate these challenges, design new solutions, find and select strategic partners and navigate complex situations.
Helping clinicians integrate technology with traditional dermatology practices, develop new treatments, manage patient data while ensuring privacy and compliance, navigate regulatory challenges, assess market competition from both start-ups and established players.
Skin Health
Neuroscience is reshaping modern medicine, paving the way for groundbreaking discoveries that enhance our understanding of the human brain and its intricate connections to overall health and wellbeing. It plays a crucial role in longevity science and it offers a combination of old and new therapies for improving quality of life and extending healthy years.
However, with incredible scientific discoveries and innovation comes a responsibility to prioritise ethical considerations. Responsible innovation in neuroscience should ensure that advances benefit all, while safeguarding human rights, independence, and personal choice in an era where technology intertwines intimately with our daily lives. It is not just about diagnosing or curing neurological diseases, it is also about respecting the dignity of every human being.
Neuroscience and Neurotech
Leading with responsible science and wisdom
_________________________________________________________________________________________________
Featured Insights
Advancements in dermatology have opened new frontiers in understanding skin health, which plays a vital role in longevity. Skin serves as the body's first line of defense and is a reflection of our overall health.
Leading with responsible science and wisdom
_________________________________________________________________________________________________
Featured Insights
Skin Health
There is increasing evidence pointing to the deep bi-directional connections between oral health and other systemic diseases, so there is a push for better integrated care and collaboration between dental practitioners, device manufacturers and medical specialists in other therapeutics areas.
Major innovations are transforming the dental practice - from digital imaging, 3D diagnostics, 3D printing, CAD/CAM and same-day crowns and restorations to AI support and biomaterial advances and finishing with research in 4D printing, smart self-adjusting materials and regenerative dentistry.
In Europe dental practitioners are therefore facing and could continue to face higher capital and technology costs, training and skill gaps, fragmented care pathways and regulatory burden from the EU MDR or the AI Act, meaning more attention will need to be paid to careful planning and new business models.
Leading with responsible science and wisdom
__________________________________________________________________________________________________
Featured Insights
Dental
Longevity research aims to extend healthy life spans through scientific advancements, studying the biological mechanisms of aging and potential interventions. The field has made significant strides with breakthroughs in genetics, regenerative medicine, and biotechnology.
However, it faces numerous ethical challenges, such as concerns over access to anti-aging therapies, potential equity issues, regulatory hurdles in clinical trials as age is not a disease and the implications of extending life. Regulatory frameworks also struggle to keep pace with rapid developments in biotechnology, leading to uncertainties about safety, long-term effects, and approval processes. Furthermore, societal attitudes towards aging and the elderly can influence public perception and acceptance of longevity science initiatives.
Leading with responsible science and wisdom
_________________________________________________________________________________________________
Featured Insights
Longevity and
Public Health
IGEA Healthcare
Strategic Advisory for Life Sciences
Switzerland, UK, Italy
contact@igeahealthcare.com
© 2025 - 2026. All rights reserved.
